Open AccessEmerging Treatment Options in Inflammatory Bowel Disease: Janus Kinases, Stem Cells, and More
Author(s) -
Benjamin Misselwitz,
Pascal Juillerat,
Michael Christian Sulz,
Britta Siegmund,
Stephan Brand
Publication year - 2020
Publication title -
digestion
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.882
H-Index - 75
eISSN - 1421-9867
pISSN - 0012-2823
DOI - 10.1159/000507782
Subject(s) - vedolizumab , janus kinase , tofacitinib , inflammatory bowel disease , medicine , immunology , ustekinumab , pharmacology , addressin , cancer research , tumor necrosis factor alpha , cytokine , integrin , adalimumab , receptor , disease , rheumatoid arthritis